
Bicalutamide
Form: Tablets
Strength: 50 mg , 150 mg
Reference Brands: Casodex®(US & EU)
Category: Oncology Cancer Care
Bicalutamide Tablets, available in 50 mg and 150 mg strengths, are widely used in the treatment of prostate cancer in both the US and EU. As a non-steroidal anti-androgen, Bicalutamide inhibits androgen receptors to block testosterone-driven cancer growth, making it an essential part of combination therapy with LHRH analogs or as monotherapy. Marketed under brands like Casodex®, it is a globally trusted oncology drug. Bicalutamide is manufactured under GMP conditions, ideal for B2B pharmaceutical sourcing, contract manufacturing, and global distribution. Its high stability and oral dosage form make it a preferred API for regulated markets. ? Short Description
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Atezolizumab
Strength: 1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View Details Get EnquiryDurvalumab
Strength: 120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View Details Get EnquirySunitinib
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View Details Get EnquiryIfosfamide
Strength: 1 g/vial,2 g/vial, 3 g/vial
Form: Injection
Reference Brands: Ifex® (US), Holoxan® (EU)
View Details Get Enquiry